Anplag 90mg tablet contains the active ingredient ticagrelor. Ticagrelor is an antiplatelet medication that belongs to the class of drugs known as P2Y12 inhibitors. It is prescribed to prevent blood clots in individuals with certain heart or blood vessel conditions.
- Acute Coronary Syndrome (ACS): Anplag is primarily used in patients with acute coronary syndrome, which includes conditions like unstable angina or heart attack (myocardial infarction). It helps prevent further blood clot formation and reduces the risk of subsequent cardiovascular events.
- Percutaneous Coronary Intervention (PCI): Ticagrelor is also prescribed to individuals who undergo percutaneous coronary intervention (PCI), a procedure to open blocked or narrowed coronary arteries. It is used in combination with aspirin to prevent stent thrombosis and improve outcomes after the procedure.
Anplag 90mg tablet, like other antiplatelet medications, may cause side effects in some individuals. Common side effects may include:
- Bleeding: The most significant side effect of ticagrelor is an increased risk of bleeding, which may manifest as nosebleeds, bruising, or prolonged bleeding from cuts or wounds.
- Shortness of Breath: Some people may experience shortness of breath or difficulty breathing, especially during the first few weeks of treatment.
- Headache: Headache can occur as a common side effect of ticagrelor use.
- Dizziness: Dizziness or lightheadedness may be experienced by some individuals.
- Nausea and Upset Stomach: Mild gastrointestinal discomfort, including nausea, may occur in some cases.
When Not to Use:
- Active Bleeding: Anplag should not be used in individuals with active pathological bleeding, such as bleeding ulcers, intracranial hemorrhage, or recent major surgery.
- History of Intracranial Hemorrhage: Individuals with a history of intracranial hemorrhage should avoid using ticagrelor, as it may increase the risk of recurrent bleeding.
- Severe Liver Impairment: Ticagrelor should be used with caution in patients with severe liver impairment, as the drug is metabolized by the liver.
- Allergy to Ticagrelor: If you have a known allergy or hypersensitivity to ticagrelor or any other component of Anplag 90mg tablet, do not use this medication.
- Concomitant Use with Strong CYP3A4 Inhibitors: Some medications that inhibit the CYP3A4 enzyme system can interact with ticagrelor and increase its blood levels, leading to an increased risk of bleeding. Avoid concurrent use with strong CYP3A4 inhibitors unless deemed necessary by a healthcare professional.
Always use Anplag 90mg tablet as prescribed by your healthcare provider and inform them of any pre-existing medical conditions or medications you are taking to avoid potential interactions or complications. If you experience any concerning side effects, contact your healthcare provider promptly.